138 related articles for article (PubMed ID: 23486588)
21. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Collins RP; Palmer BR; Pilbrow AP; Frampton CM; Troughton RW; Yandle TG; Skelton L; Richards AM; Cameron VA
Am Heart J; 2006 Aug; 152(2):312-20. PubMed ID: 16875916
[TBL] [Abstract][Full Text] [Related]
22. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
de Groote P; Lamblin N; Helbecque N; Mouquet F; Hermant X; Amouyel P; Dallongeville J; Bauters C
Am Heart J; 2006 Oct; 152(4):736-41. PubMed ID: 16996850
[TBL] [Abstract][Full Text] [Related]
23. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
Taegtmeyer AB; Breen JB; Rogers P; Johnson PH; Smith J; Smolenski RT; Banner NR; Yacoub MH; Barton PJ
Am J Cardiol; 2009 May; 103(10):1457-62. PubMed ID: 19427446
[TBL] [Abstract][Full Text] [Related]
24. Genotype distributions in top-level soccer players: a role for ACE?
Juffer P; Furrer R; González-Freire M; Santiago C; Verde Z; Serratosa L; Morate FJ; Rubio JC; Martin MA; Ruiz JR; Arenas J; Gómez-Gallego F; Lucia A
Int J Sports Med; 2009 May; 30(5):387-92. PubMed ID: 19277943
[TBL] [Abstract][Full Text] [Related]
25. AMPD1 gene polymorphism and the vasodilatory response to ischemia.
Hand BD; Roth SM; Roltsch MH; Park JJ; Kostek MC; Ferrell RE; Brown MD
Life Sci; 2006 Sep; 79(15):1413-8. PubMed ID: 16707139
[TBL] [Abstract][Full Text] [Related]
26. Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency.
Rannou F; Scotet V; Marcorelles P; Monnoyer R; Le Maréchal C
PLoS One; 2017; 12(11):e0187266. PubMed ID: 29095874
[TBL] [Abstract][Full Text] [Related]
27. The effect of AMPD1 genotype on blood flow response to sprint exercise.
Norman B; Nygren AT; Nowak J; Sabina RL
Eur J Appl Physiol; 2008 May; 103(2):173-80. PubMed ID: 18224333
[TBL] [Abstract][Full Text] [Related]
28. Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
Safranow K; Czyzycka E; Binczak-Kuleta A; Rzeuski R; Skowronek J; Wojtarowicz A; Jakubowska K; Olszewska M; Loniewska B; Kaliszczak R; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
Scand J Clin Lab Invest; 2009; 69(1):102-12. PubMed ID: 18855224
[TBL] [Abstract][Full Text] [Related]
29. Identification of Two Novel Single Nucleotide Polymorphisms in the Promoter Region of the Pig AMP Deaminase 1 Gene Associated with Carcass Traits.
Wang L; Chao Z; Wang Y
DNA Cell Biol; 2018 Nov; 37(11):896-902. PubMed ID: 30234378
[TBL] [Abstract][Full Text] [Related]
30. C34T mutation of the AMPD1 gene in an elite white runner.
Lucia A; Martin MA; Esteve-Lanao J; San Juan AF; Rubio JC; Oliván J; Arenas J
Br J Sports Med; 2006 Mar; 40(3):e7. PubMed ID: 16505069
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization and expression patterns of AMP deaminase1 (AMPD1) in porcine skeletal muscle.
Wang L; Mo X; Xu Y; Zuo B; Lei M; Li F; Jiang S; Deng C; Xiong Y
Comp Biochem Physiol B Biochem Mol Biol; 2008 Oct; 151(2):159-66. PubMed ID: 18638563
[TBL] [Abstract][Full Text] [Related]
32. AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance.
Hanisch F; Joshi P; Zierz S
J Neurol; 2008 Mar; 255(3):318-22. PubMed ID: 18338202
[TBL] [Abstract][Full Text] [Related]
33. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects.
Norman B; Sabina RL; Jansson E
J Appl Physiol (1985); 2001 Jul; 91(1):258-64. PubMed ID: 11408438
[TBL] [Abstract][Full Text] [Related]
34. A genetic predisposition score for muscular endophenotypes predicts the increase in aerobic power after training: the CAREGENE study.
Thomaes T; Thomis M; Onkelinx S; Fagard R; Matthijs G; Buys R; Schepers D; Cornelissen V; Vanhees L
BMC Genet; 2011 Oct; 12():84. PubMed ID: 21967077
[TBL] [Abstract][Full Text] [Related]
35. Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al.
Riksen NP; Rongen GA; Smits P; van Riel P; Barrera P
Arthritis Rheum; 2007 Feb; 56(2):694; author reply 694-5. PubMed ID: 17265507
[No Abstract] [Full Text] [Related]
36. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
[TBL] [Abstract][Full Text] [Related]
37. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
[TBL] [Abstract][Full Text] [Related]
38. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
Loh E; Rebbeck TR; Mahoney PD; DeNofrio D; Swain JL; Holmes EW
Circulation; 1999 Mar; 99(11):1422-5. PubMed ID: 10086964
[TBL] [Abstract][Full Text] [Related]
39. AMPD1: a novel therapeutic target for reversing insulin resistance.
Cheng J; Morisaki H; Toyama K; Sugimoto N; Shintani T; Tandelilin A; Hirase T; Holmes EW; Morisaki T
BMC Endocr Disord; 2014 Dec; 14():96. PubMed ID: 25511531
[TBL] [Abstract][Full Text] [Related]
40. Does the C34T mutation in AMPD1 alter exercise capacity in the elderly?
Pérez M; Martin MA; Cañete S; Rubio JC; Fernández-Moreira D; San Juan AF; Gómez-Gallego F; Santiago C; Arenas J; Lucia A
Int J Sports Med; 2006 Jun; 27(6):429-35. PubMed ID: 16767606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
